Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/5/2009

ue 75 -- 75 -- TOTAL REVENUE 18,364 389 21,694 588 OPERATING EXPENSES: Cost of services -- 14 -- 14 Research and development: Non-cash compensation 361 251 562 (729) Other research and development 1,456 4,242 2,830 35,069 Total research and development 1,817 4,493 3,392 34,340 Selling, general and administrative: Non-cash compensation 1,028 1,767 1,398 3,484 Other selling, general and administrative 1,528 2,078 2,569 3,965 Total selling, general and administrative 2,556 3,845 3,967 7,449 TOTAL OPERATING EXPENSES 4,373 8,352 7,359 41,803 OPERATING INCOME (LOSS) 13,991 (7,963) 14,335 (41,215) OTHER INCOME (EXPENSE): Interest and other income (expense), net 141 274 248 (929) INCOME (LOSS) FROM CONTINUING OPERATIONS 14,132 (7,689) 14,583 (42,144) Loss from discontinued operations -- (8) -- (89) NET INCOME (LOSS) $ 14,132 $ (7,697) $ 14,583 $ (42,233) NET INCOME (LOSS)PER COMMON SHARE Basic $ 0.30 $ (0.17) $ 0.30 $ (0.96) Diluted $ 0.29 $ (0.17) $ 0.30 $ (0.96) SHARES USED IN COMPUTING NET LOSS PER COMMON SHARE Basic 47,855,425 44,095,873 47,854,664 43,906,974 Diluted 48,189,552 44,095,873 48,149,600 43,906,974 Balance Sheet Information: June 30,
'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Dr. Ingrid Warmuth and Anamaria Newport, MHS, PA-C, with locations ... an Open House at their Swedesboro location, 95 Woodstown Road. ... 10 AM to 2 PM. , During the open ... be on hand to talk to people about the benefits ... cosmetic consultations. There will also be specials offered, such as ...
(Date:5/24/2013)... 2013 Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients, ... Ph.D., the Company,s Vice President, Biology and ... Corporate Communications, will present an overview of Senomyx,s technology ... Eastern Time (7:25 a.m. Pacific Time) during the Citi ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a ... research and development, sales and marketing of premium ... today that it is awarding exclusive Vestiage territories ... Reluma Skin Illuminating Facial Care. Qualified applicants can ... an email to info(at)vestiageinc(dot)com and putting RELUMA in ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... AstraZeneca Exec to Lead Hong Kong-based subsidiary Pangu BioPharmaSAN ... biopharmaceutical company focused on discovery and development of an ... multiple disease indications, today announced that Dr. James Cai ... Clinical Development at aTyr Pharma and President of Pangu ...
... & Sullivan recognizes BioTrove, Inc. with the 2009 ... Strategy Leadership of the Year. The annual ... most significant drug-discovery innovations and acknowledgments by life ... specializing in drug acceleration and pipeline assessment technologies, ...
... One Corporation (Pink Sheets: MNCN), announced today that its ... serve as the company,s Chief Financial Officer, effective March ... said, "Pat brings a strong background in finance to ... financial expertise will be great assets to Mach One ...
Cached Biology Technology:Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 2Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 2Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 4Mach One Announces Appointment of Chief Financial Officer 2
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
(Date:5/22/2013)... The discovery of potential environmental and human health ... batteries each year has led scientists to recommend ... reuse of lithium-ion (Li-ion) battery materials. That,s the ... journal Environmental Science & Technology . , ... Li-ion batteries have become mainstays for powering everything ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in Bioengineering and Biotechnology 2Tests lead to doubling of fuel cell life 2
... counters prevailing thought, a study in mice has found ... "fat-burning" can actually increase energy expenditure and help lower ... the JBC, might lead to some new ... warm-blooded animals need to continually "burn fat" in order ...
... filling such an important niche in ocean communities that ... however, that sea otters can have even farther-reaching effects ... of another top predator: the bald eagle. ... of 250 feet and function much like trees in ...
... 2008) To help improve the success of oyster ... Center for Environmental Science researcher Dr. Elizabeth North is ... study to determine when oysters spawn and where their ... is supported by a $750,000 competitive grant from the ...
Cached Biology News:Making metabolism more inefficient can reduce obesity 2Decline in Alaskan sea otters affects bald eagles' diet 2Decline in Alaskan sea otters affects bald eagles' diet 3
Rat Hepatocytes (RH) (>3,000,000 cells)...
... of proteomics demands the detection of very ... of the AXIMA-CFRplus with improved resolution (20,000) ... provides increased confidence in protein identification. The ... sensitivity, automated sample target handling and the ...
...
... The new MALDI O-TOF creates a ... on an orthogonal platform that has been ... the University of Manitoba. , As the ... orthogonal design and collisional cooling, the prOTOF ...
Biology Products: